✦ LIBER ✦

Phase II trial of galactitol 1,2:5,6-dianhydro (NSC 132313) in the treatment of advanced gynecologic malignancies: A gynecologic oncology group study

✍ Scribed by Frederick B. Stehman; Johannes Blom; John A. Blessing; Clarence E. Ehrlich; Charles Mangan

Book ID: 119052180
Publisher: Elsevier Science
Year: 1983
Tongue: English
Weight: 641 KB
Volume: 15
Category: Article
ISSN: 0090-8258
DOI: 10.1016/0090-8258(83)90056-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of didemnin B (NSC No.

A phase II trial of didemnin B (NSC No. 325319) in advanced and recurrent cervical carcinoma: A Gynecologic Oncology Group study

✍ Allan J. Jacobs; John A. Blessing; Alan Munoz 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 269 KB

Phase II and pharmacokinetic study of hi

Phase II and pharmacokinetic study of high-dose methotrexate in the treatment of advanced gynecologic malignancy: A Southwest Oncology Group trial

✍ Robert D. Hilgers; David S. Alberts; James C. Standefer; Betty E. Skipper; Nancy 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 553 KB

Phase II trial of cisplatin in advanced

Phase II trial of cisplatin in advanced or recurrent cancer of the vagina: A gynecologic oncology group study

✍ J.Tate Thigpen; John A. Blessing; Howard D. Homesley; Jonathan S. Berek; William 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 284 KB

Phase II trial of nab-paclitaxel in the

Phase II trial of nab-paclitaxel in the treatment of recurrent or persistent advanced cervix cancer: A gynecologic oncology group study

✍ David S. Alberts; John A. Blessing; Lisa M. Landrum; David P. Warshal; Lainie P. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 209 KB

Human lymphoblastoid interferon in the t

Human lymphoblastoid interferon in the treatment of advanced epithelial ovarian malignancies: A Gynecologic Oncology Group study

✍ Abdulhay, Gazi; DiSaia, Philip J.; Blessing, John A.; Creasman, William T. 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 650 KB

Mitoxantrone in the treatment of advance

Mitoxantrone in the treatment of advanced non-squamous carcinoma of the cervix (A phase II trial of the gynecologic oncology group)

✍ Hyman B. Muss; Brian N. Bundy; Howard D. Homesley; George Wilbanks 📂 Article 📅 1987 🏛 Springer US 🌐 English ⚖ 247 KB

Twenty-five evaluable patients with advanced non-squamous carcinoma of the uterine cervix were treated with mitoxantrone 12 mg/m 2 every three weeks. All patients had good performance status and measurable disease and'only 11 had received prior chemotherapy. One complete and one partial response wer